Thanks to improved treatments, patients with cancer are living longer. Some of those treatments, however, are associated with cardiotoxicities that can put patients at risk for heart problems, such as heart failure, difficult-to-control blood pressure, coronary artery disease and arrhythmias. The goal of the Cardio-Oncology Program at MUSC Health, co-directed by Bhavadharini Ramu, M.D. and Marian H. Taylor, M.D., is to protect patients’ hearts before, during and after cancer treatments.
In this video, Dr. Ramu discusses the expertise and technology needed to appropriately identify and manage cancer patients at risk for heart disease so that precautions can be taken to minimize damage to their heart as they receive life-saving cancer treatment. She also explains how existing cardiotoxicities in patients who have already undergone treatment are addressed.
Dr. Bhavadharini Ramu joined MUSC in 2016 as assistant professor, specializing in advanced heart failure and heart transplantation. After receiving her medical degree from Stanley Medical College in India, she completed her residency in ...
Medical University of South Carolina College of Medicine
Medical University of South Carolina
Medical University of South Carolina in Rheumatology
Medical University ...